Lazard Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
59,863
-91,165
| -60% | -$2.18M | ﹤0.01% | 1137 |
|
|
2025
Q1 | $3.75M | Buy |
151,028
+107,537
| +247% | +$2.67M | 0.01% | 769 |
|
|
2024
Q4 | $818K | Buy |
+43,491
| New | +$818K | ﹤0.01% | 1225 |
|
|
2023
Q4 | – | Sell |
-1,030
| Closed | -$31K | – | 2420 |
|
|
2023
Q3 | $31K | Buy |
+1,030
| New | +$31K | ﹤0.01% | 2013 |
|
|
2023
Q2 | – | Sell |
-1,544
| Closed | -$63K | – | 2485 |
|
|
2023
Q1 | $63K | Buy |
+1,544
| New | +$63K | ﹤0.01% | 1721 |
|
|
2022
Q2 | – | Sell |
-3,282
| Closed | -$250K | – | 2526 |
|
|
2022
Q1 | $250K | Sell |
3,282
-652
| -17% | -$49.7K | ﹤0.01% | 1217 |
|
|
2021
Q4 | $236K | Buy |
+3,934
| New | +$236K | ﹤0.01% | 1243 |
|
|
2020
Q3 | – | Sell |
-3,645
| Closed | -$191K | – | 1708 |
|
|
2020
Q2 | $191K | Sell |
3,645
-523
| -13% | -$27.4K | ﹤0.01% | 925 |
|
|
2020
Q1 | $139K | Buy |
4,168
+3,351
| +410% | +$112K | ﹤0.01% | 951 |
|
|
2019
Q4 | $37K | Sell |
817
-2,854
| -78% | -$129K | ﹤0.01% | 1117 |
|
|
2019
Q3 | $139K | Buy |
+3,671
| New | +$139K | ﹤0.01% | 957 |
|